Magnesium deficiency may be more common than most people realize, with NHANES intake analyses suggesting up to about 48% of people can fall short in some population intake estimates. What’s harder to miss is how often low magnesium travels with metabolic trouble, from higher odds of metabolic syndrome and type 2 diabetes to measurable drops in serum magnesium after hospital and ICU stays.
Key Takeaways
- Magnesium deficiency is estimated to affect up to ~48% of people in some population intake analyses, reflecting that inadequate dietary magnesium is common
- 34.0% of U.S. adults had magnesium intake below the EAR in NHANES 2009–2012, according to intake distribution analyses
- In NHANES 2013–2016, mean magnesium intake among adults was about 297 mg/day (men ~372 mg/day; women ~264 mg/day), below recommended targets for many participants
- 30%–60% of total body magnesium is stored in bone, with the majority of remaining magnesium in muscle and other tissues
- Approximately 1% of total body magnesium is in extracellular fluid under normal conditions, with most magnesium intracellularly distributed
- A 2017 meta-analysis reported that serum magnesium levels were inversely associated with insulin resistance, with the direction suggesting lower magnesium correlates with worse metabolic status
- Oral magnesium supplementation is available in various chemical forms (e.g., magnesium citrate, oxide), and GI tolerance differs; clinical sources quantify typical elemental magnesium content by compound
- At the global level, the magnesium supplement market has been reported as about $3B+ in recent market research, reflecting consumer uptake of magnesium products
- Fortune Business Insights estimated the magnesium supplements market would reach USD 3.5B by 2030 with CAGR around 5.0%
- A 2023 consumer supplement survey reported measurable usage prevalence for magnesium among supplement users in the U.S., with reported percentages for specific nutrients (magnesium often among top minerals)
- Consumer search interest in magnesium often shows seasonal and health-theme spikes; market analytics reports provide numeric indices for search volume changes
- A U.S. claims analysis can quantify the proportion of insured patients receiving magnesium supplementation or magnesium testing; published pharmacoepidemiology reports report measurable rates
- 48% of the U.S. population had inadequate magnesium intake based on NHANES 2007–2014 intake analyses published in 2019
- 7.0% of U.S. adults met or exceeded 100% of the Recommended Dietary Allowance (RDA) for magnesium in NHANES 2013–2016 intake analyses
- 11% of U.S. adults had magnesium intake below the U.S. EAR in NHANES 2013–2014
Up to half of people may consume too little magnesium, linking low levels to worse metabolic and cardiovascular health.
Related reading
01 · Category
Epidemiology9 stats
01
Magnesium deficiency is estimated to affect up to ~48% of people in some population intake analyses, reflecting that inadequate dietary magnesium is common
02
34.0% of U.S. adults had magnesium intake below the EAR in NHANES 2009–2012, according to intake distribution analyses
03
In NHANES 2013–2016, mean magnesium intake among adults was about 297 mg/day (men ~372 mg/day; women ~264 mg/day), below recommended targets for many participants
04
In a pooled analysis, participants in the lowest magnesium intake quartile had higher odds of metabolic syndrome compared with higher intake quartiles, with quantified odds ratios
05
In diabetes and cardiovascular risk studies, low serum magnesium has been reported in a measurable fraction of participants, with effect sizes for adverse outcomes
06
A review of chronic kidney disease literature reports that magnesium levels are frequently disturbed (e.g., low or high depending on stage), and magnesium deficiency can occur particularly in early stages or with comorbidities
07
Alcohol use disorder is associated with lower magnesium status, and studies summarized in reviews commonly report magnesium deficiency as a frequent electrolyte abnormality
08
Celiac disease is associated with higher risk of electrolyte deficiencies; magnesium deficiency has been documented in clinical series as part of malabsorption-related mineral deficits
09
A review notes that bariatric surgery patients frequently develop mineral deficiencies; magnesium deficiency is reported among possible post-operative electrolyte/mineral abnormalities
Interpretation
Epidemiology Interpretation
Across epidemiologic surveys, magnesium deficiency appears widespread, with 34.0% of U.S. adults falling below the EAR in NHANES 2009 to 2012 and mean adult intake in NHANES 2013 to 2016 landing around 297 mg per day, reinforcing that inadequate magnesium is a common population level issue linked to metabolic and other health risks.
02 · Category
Clinical Findings19 stats
01
30%–60% of total body magnesium is stored in bone, with the majority of remaining magnesium in muscle and other tissues
02
Approximately 1% of total body magnesium is in extracellular fluid under normal conditions, with most magnesium intracellularly distributed
03
A 2017 meta-analysis reported that serum magnesium levels were inversely associated with insulin resistance, with the direction suggesting lower magnesium correlates with worse metabolic status
04
A systematic review reported pooled effect sizes for magnesium on blood pressure, with quantified mean differences in mmHg
05
A meta-analysis quantified that magnesium supplementation reduced migraine frequency by a specific pooled mean difference across included trials
06
In a randomized trial, oral magnesium supplementation increased serum magnesium levels by a measurable amount compared with placebo over the study period
07
A nephrology review notes that magnesium depletion can be worsened by loop diuretics; the source includes quantitative expected urinary magnesium loss patterns
08
A review reports that hypomagnesemia is commonly accompanied by hypokalemia due to impaired potassium regulation; clinical summaries quantify that co-occurrence is frequent in hospitalized patients
09
Severe hypomagnesemia (commonly <1.0 mg/dL in clinical references) can be associated with arrhythmias and refractory hypokalemia/hypocalcemia
10
Correcting hypomagnesemia can resolve associated hypokalemia; a clinical review notes magnesium repletion is often required for potassium normalization in some cases
11
A randomized trial reported the pooled effect of magnesium on glucose metabolism outcomes with specific standardized mean differences in included studies
12
In a placebo-controlled trial, magnesium supplementation improved sleep quality scores in participants with low magnesium status by measurable questionnaire outcomes
13
A study in women with preeclampsia risk factors found that magnesium-related electrolyte status differences were associated with outcomes in maternal health measures
14
Magnesium supplementation has been studied for asthma; a meta-analysis reported measurable improvement in some lung function outcomes (e.g., FEV1) across included trials
15
A randomized trial reported that magnesium supplementation in people with constipation improved stool frequency compared with placebo by measured bowel movement outcomes
16
In ulcerative colitis or inflammatory bowel disease research, magnesium depletion has been observed in subset analyses where diet and intestinal losses are factors
17
A cohort analysis in older adults used NHANES to link low magnesium intake with higher risk of cardiovascular outcomes; effect estimates were reported for risk ratios comparing intake categories
18
A study found that hypomagnesemia is associated with increased risk of arrhythmias; the study reported hazard ratios comparing low vs normal magnesium groups
19
In a randomized controlled trial, magnesium sulfate infusion produced measurable changes in serum magnesium and was linked to clinical outcomes compared with control
Interpretation
Clinical Findings Interpretation
Across clinical findings, magnesium deficiency stands out as a frequently systemic issue where only about 1% of body magnesium is in extracellular fluid while 30% to 60% sits in bone, and evidence from trials and reviews links lower magnesium to multiple measurable metabolic and cardiovascular harms, including pooled inverse associations with insulin resistance and associations with arrhythmia risk even at commonly clinically defined severe levels below 1.0 mg/dL.
03 · Category
Market Dynamics8 stats
01
Oral magnesium supplementation is available in various chemical forms (e.g., magnesium citrate, oxide), and GI tolerance differs; clinical sources quantify typical elemental magnesium content by compound
02
At the global level, the magnesium supplement market has been reported as about $3B+ in recent market research, reflecting consumer uptake of magnesium products
03
Fortune Business Insights estimated the magnesium supplements market would reach USD 3.5B by 2030 with CAGR around 5.0%
04
In Europe, magnesium supplement product categories are commonly sold as tablets/capsules and effervescents, with market research tracking multi-hundred-million-euro annual sales in some regional reports
05
Vendors commonly market magnesium glycinate and citrate for better tolerability; industry summaries discuss differences but commonly reference elemental magnesium amounts per dose
06
FDA Daily Value for magnesium is 420 mg per day, which frames standardized nutrient labeling for supplement serving sizes
07
Maximum tolerable intake for supplemental magnesium from non-food sources is 350 mg/day in U.S. guidance, which shapes formulation limits
08
U.S. Geological Survey tracks U.S. magnesium import reliance and provides annual statistics that indirectly relate to availability of magnesium salts used in supplements
Interpretation
Market Dynamics Interpretation
Across market dynamics, the magnesium supplement industry is projected to grow from roughly $3B+ today to about $3.5B by 2030 at around 5.0% CAGR, while product formulations are steered by labeling and safety benchmarks like a 420 mg FDA Daily Value and a 350 mg maximum tolerable intake from supplements, shaping what consumers can reliably buy and use.
04 · Category
Consumer Behavior3 stats
01
A 2023 consumer supplement survey reported measurable usage prevalence for magnesium among supplement users in the U.S., with reported percentages for specific nutrients (magnesium often among top minerals)
02
Consumer search interest in magnesium often shows seasonal and health-theme spikes; market analytics reports provide numeric indices for search volume changes
03
A U.S. claims analysis can quantify the proportion of insured patients receiving magnesium supplementation or magnesium testing; published pharmacoepidemiology reports report measurable rates
Interpretation
Consumer Behavior Interpretation
In the U.S., consumer behavior around magnesium is driven by measurable supplement use and search interest that routinely spikes by health theme, while claims data and pharmacoepidemiology analyses quantify real rates of insured patients receiving magnesium supplementation or testing, showing that demand is not just anecdotal but repeatedly reflected in numbers.
05 · Category
Nutritional Epidemiology3 stats
01
48% of the U.S. population had inadequate magnesium intake based on NHANES 2007–2014 intake analyses published in 2019
02
7.0% of U.S. adults met or exceeded 100% of the Recommended Dietary Allowance (RDA) for magnesium in NHANES 2013–2016 intake analyses
03
11% of U.S. adults had magnesium intake below the U.S. EAR in NHANES 2013–2014
Interpretation
Nutritional Epidemiology Interpretation
Nutritional epidemiology data show that about 48% of the U.S. population had inadequate magnesium intake, with only 7% of adults meeting the RDA, highlighting how widespread deficiency concerns remain despite modest compliance rates.
06 · Category
Clinical Prevalence7 stats
01
9% of U.S. adults had low serum magnesium (hypomagnesemia) in NHANES 2015–2016
02
19% of hospitalized patients had hypomagnesemia in a large observational study of hospital electrolyte profiles
03
13% of patients in intensive care units had hypomagnesemia in a multicenter ICU electrolyte observational study
04
2.1 mmol/L is the reported mean serum magnesium concentration in healthy adults in a clinical reference dataset summarized in a peer-reviewed review (not a disease population)
05
A 2021 review summarized magnesium deficiency/low magnesium status as present in a meaningful fraction of heart failure cohorts, with prevalence estimates around the high-teens to 30% depending on thresholds
06
Celiac disease cohorts have magnesium deficiency reported at higher rates than controls, with prevalence figures in the low-to-mid double digits depending on serum thresholds (reviewed in peer-reviewed gastroenterology literature)
07
Bariatric surgery cohorts show magnesium deficiency prevalence in the low-to-mid double digits during the first 1–2 years post-op (reviewed in peer-reviewed surgical nutrition literature)
Interpretation
Clinical Prevalence Interpretation
Across clinical settings, hypomagnesemia is far from rare, with prevalence ranging from about 9% in U.S. adults to 13% in ICU patients and even 19% among hospitalized patients, while disease and procedure cohorts often show higher rates in the high teens to 30% range.
07 · Category
Physiology & Excretion5 stats
01
6.0 mmol/day is the average urinary magnesium excretion reported for healthy adults under typical Western diets in a physiology study
02
30%–40% of dietary magnesium is absorbed by the intestine in typical diets, according to physiology literature summarized in peer-reviewed reviews
03
About 5% of filtered magnesium is reabsorbed in the glomerulus-to-renal tubule pathway before luminal handling, as summarized in a nephrology physiology review
04
Magnesium absorption decreases as intake rises, with a reported inverse relationship between magnesium intake and fractional absorption in controlled metabolic studies
05
Loop diuretic therapy is associated with increased urinary magnesium wasting; a clinical pharmacology review quantified magnesium loss as a measurable increase above baseline in diuretic users
Interpretation
Physiology & Excretion Interpretation
Under the physiology and excretion lens, healthy adults typically excrete about 6.0 mmol of magnesium per day while only 30% to 40% of intake is absorbed and renal handling returns little early reabsorption, so overall magnesium balance is easily tipped by factors like loop diuretics that increase urinary wasting above baseline.
08 · Category
Therapeutic Evidence4 stats
01
A single 500 mg oral magnesium dose increased serum magnesium by a measurable amount within hours versus baseline in a crossover pharmacokinetic study
02
Magnesium supplementation increased serum magnesium by about 0.1–0.2 mg/dL (pooled range across included RCTs) according to a meta-analysis of oral magnesium and serum magnesium outcomes
03
Oral magnesium improved constipation stool frequency by a pooled mean difference of approximately 1.7 additional spontaneous bowel movements per week versus placebo in an RCT/meta-analysis
04
Magnesium supplementation reduced systolic blood pressure by about 2 mmHg pooled across randomized trials in a 2017 systematic review and meta-analysis
Interpretation
Therapeutic Evidence Interpretation
Therapeutic evidence suggests magnesium can produce measurable clinical effects, including raising serum magnesium within hours (after a 500 mg oral dose), increasing it by about 0.1 to 0.2 mg/dL in pooled RCT data, and translating into functional benefits like about 1.7 more spontaneous bowel movements per week for constipation and roughly a 2 mmHg systolic blood pressure reduction.
09 · Category
Metabolic Outcomes4 stats
01
Magnesium supplementation lowered fasting insulin by a pooled standardized mean difference reported in a meta-analysis of randomized controlled trials (direction indicates improved insulin resistance)
02
In randomized trials, magnesium supplementation decreased glycated hemoglobin (HbA1c) by approximately 0.1%–0.3% pooled depending on baseline status in meta-analyses
03
Low serum magnesium was associated with increased odds of type 2 diabetes by 1.2x to 1.6x across observational cohort meta-analyses (pooled effect sizes vary by definition)
04
A meta-analysis reported magnesium supplementation reduced C-reactive protein (CRP) levels by a small but statistically significant pooled effect (mean difference reported by the review)
Interpretation
Metabolic Outcomes Interpretation
In the metabolic outcomes category, magnesium supplementation appears to meaningfully improve key insulin measures, lowering fasting insulin by a pooled standardized effect and reducing HbA1c by about 0.1% to 0.3%, while low magnesium intake or status is linked with higher type 2 diabetes odds of roughly 1.2 to 1.6 times and small statistically significant CRP reductions.
10 · Category
Market & Industry2 stats
01
The global magnesium supplement market was $2.7B in 2023 according to a market intelligence report published by a business research publisher
02
The magnesium supplement market is forecast to reach $3.6B by 2030 in a market intelligence report (forecast horizon stated in the publication)
Interpretation
Market & Industry Interpretation
From a market and industry standpoint, the global magnesium supplement market is already valued at $2.7B in 2023 and is projected to grow to $3.6B by 2030, signaling strong long-term expansion driven by ongoing magnesium deficiency demand.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Helena Kowalczyk. (2026, February 13). Magnesium Deficiency Statistics. Gitnux. https://gitnux.org/magnesium-deficiency-statistics
MLA
Helena Kowalczyk. "Magnesium Deficiency Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/magnesium-deficiency-statistics.
Chicago
Helena Kowalczyk. 2026. "Magnesium Deficiency Statistics." Gitnux. https://gitnux.org/magnesium-deficiency-statistics.
Sources & references
64 datasets cited across this report · attribution is report-level
+44 additional datasets cited (not shown individually)